Distinct Mechanisms of CD4+ and CD8+ T-Cell Activation and Bystander Apoptosis Induced by Human Immunodeficiency Virus Type 1 Virions

ABSTRACT Apoptosis of uninfected bystander T cells contributes to T-cell depletion during human immunodeficiency virus type 1 (HIV-1) infection. HIV-1 envelope/receptor interactions and immune activation have been implicated as contributors to bystander apoptosis. To better understand the relationship between T-cell activation and bystander apoptosis during HIV-1 pathogenesis, we investigated the effects of the highly cytopathic CXCR4-tropic HIV-1 variant ELI6 on primary CD4+ and CD8+ T cells. Infection of primary T-cell cultures with ELI6 induced CD4+ T-cell depletion by direct cell lysis and bystander apoptosis. Exposure of primary CD4+ and CD8+ T cells to nonreplicating ELI6 virions induced bystander apoptosis through a Fas-independent mechanism. Bystander apoptosis of CD4+ T cells required direct contact with virions and Env/CXCR4 binding. In contrast, the apoptosis of CD8+ T cells was triggered by a soluble factor(s) secreted by CD4+ T cells. HIV-1 virions activated CD4+ and CD8+ T cells to express CD25 and HLA-DR and preferentially induced apoptosis in CD25+HLA-DR+ T cells in a CXCR4-dependent manner. Maximal levels of binding, activation, and apoptosis were induced by virions that incorporated MHC class II and B7-2 into the viral membrane. These results suggest that nonreplicating HIV-1 virions contribute to chronic immune activation and T-cell depletion during HIV-1 pathogenesis by activating CD4+ and CD8+ T cells, which then proceed to die via apoptosis. This mechanism may represent a viral immune evasion strategy to increase viral replication by activating target cells while killing immune effector cells that are not productively infected.

[1]  M. Tremblay,et al.  Insertion of Host-Derived Costimulatory Molecules CD80 (B7.1) and CD86 (B7.2) into Human Immunodeficiency Virus Type 1 Affects the Virus Life Cycle , 2004, Journal of Virology.

[2]  E. De Clercq,et al.  Apoptosis of Bystander T Cells Induced by Human Immunodeficiency Virus Type 1 with Increased Envelope/Receptor Affinity and Coreceptor Binding Site Exposure , 2004, Journal of Virology.

[3]  T. Chun,et al.  Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Sodroski,et al.  Cytolysis by CCR5-Using Human Immunodeficiency Virus Type 1 Envelope Glycoproteins Is Dependent on Membrane Fusion and Can Be Inhibited by High Levels of CD4 Expression , 2003, Journal of Virology.

[5]  E. De Clercq,et al.  In Vivo Evolution of Human Immunodeficiency Virus Type 1 toward Increased Pathogenicity through CXCR4-Mediated Killing of Uninfected CD4 T Cells , 2003, Journal of Virology.

[6]  J. Sprent,et al.  Direct stimulation of naïve T cells by membrane vesicles from antigen-presenting cells: Distinct roles for CD54 and B7 molecules , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Gougeon,et al.  Cell death and immunity: Apoptosis as an HIV strategy to escape immune attack , 2003, Nature Reviews Immunology.

[8]  C. Payá,et al.  CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells , 2002, AIDS.

[9]  Richard A Lempicki,et al.  HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Corbeil,et al.  Effects of Antiretroviral Drugs on Human Immunodeficiency Virus Type 1-Induced CD4+ T-Cell Death , 2002, Journal of Virology.

[11]  M. Lenardo,et al.  Cytopathic Killing of Peripheral Blood CD4+ T Lymphocytes by Human Immunodeficiency Virus Type 1 Appears Necrotic rather than Apoptotic and Does Not Require env , 2002, Journal of Virology.

[12]  Z. Grossman,et al.  CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause? , 2002, Nature Medicine.

[13]  Z. Bentwich,et al.  CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention , 2002, AIDS.

[14]  J. Altman,et al.  Increased CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells. , 2001, Immunity.

[15]  E. De Clercq,et al.  HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling. , 2001, Blood.

[16]  J. Lifson,et al.  Differential Incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and Major Histocompatibility Complex Class I and II Molecules into Human Immunodeficiency Virus Type 1 Virions and Microvesicles: Implications for Viral Pathogenesis and Immune Regulation , 2001, Journal of Virology.

[17]  R. Compans,et al.  HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis. , 2001, Virology.

[18]  J. McCune,et al.  The dynamics of CD4+ T-cell depletion in HIV disease , 2001, Nature.

[19]  W. Greene,et al.  HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell , 2001, Nature.

[20]  Nancy Dumais,et al.  Attachment of Human Immunodeficiency Virus-1 (HIV-1) Particles Bearing Host-encoded B7-2 Proteins Leads to Nuclear Factor-κB- and Nuclear Factor of Activated T Cells-dependent Activation of HIV-1 Long Terminal Repeat Transcription* , 2001, The Journal of Biological Chemistry.

[21]  J. Lifson,et al.  Partial Activation and Induction of Apoptosis in CD4+ and CD8+ T Lymphocytes by Conformationally Authentic Noninfectious Human Immunodeficiency Virus Type 1 , 2001, Journal of Virology.

[22]  C. Payá,et al.  Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes. , 2001, The Journal of clinical investigation.

[23]  J. Sodroski,et al.  Importance of Membrane Fusion Mediated by Human Immunodeficiency Virus Envelope Glycoproteins for Lysis of Primary CD4-Positive T Cells , 2000, Journal of Virology.

[24]  M. Malim,et al.  Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding , 2000, Journal of Virology.

[25]  H. Schuitemaker,et al.  T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock , 2000, Nature Immunology.

[26]  J. Grivel,et al.  Human Immunodeficiency Virus Type 1 Induces Apoptosis in CD4+ but Not in CD8+ T Cells in Ex Vivo-Infected Human Lymphoid Tissue , 2000, Journal of Virology.

[27]  N. Oyaizu,et al.  CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway. , 2000, Blood.

[28]  P. Lipsky,et al.  Cutting Edge: Stromal Cell-Derived Factor-1 Is a Costimulator for CD4+ T Cell Activation1 , 2000, The Journal of Immunology.

[29]  Dzung H. Nguyen,et al.  Evidence for Budding of Human Immunodeficiency Virus Type 1 Selectively from Glycolipid-Enriched Membrane Lipid Rafts , 2000, Journal of Virology.

[30]  I. Chen,et al.  Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis through Caspase Activation , 2000, Journal of Virology.

[31]  E. De Clercq,et al.  Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo. , 1999, The Journal of clinical investigation.

[32]  J. Hoxie,et al.  Exclusion of HIV coreceptors CXCR4, CCR5, and CCR3 from the HIV envelope. , 1999, AIDS research and human retroviruses.

[33]  Wildt,et al.  Induction of phosphorylation and intracellular association of CC chemokine receptor 5 and focal adhesion kinase in primary human CD4+ T cells by macrophage-tropic HIV envelope. , 1999, Journal of immunology.

[34]  R. Osathanondh,et al.  Apoptosis Induced by Infection of Primary Brain Cultures with Diverse Human Immunodeficiency Virus Type 1 Isolates: Evidence for a Role of the Envelope , 1999, Journal of Virology.

[35]  R. Grunow,et al.  CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals. , 1999, Immunology letters.

[36]  J. Jason,et al.  Increased expression of CD80 and CD86 in in vitro-infected CD3+ cells producing cytoplasmic HIV type 1 p24. , 1999, AIDS research and human retroviruses.

[37]  Louis J. Picker,et al.  Changes in thymic function with age and during the treatment of HIV infection , 1998, Nature.

[38]  J. Paquette,et al.  Level of ICAM-1 Surface Expression on Virus Producer Cells Influences both the Amount of Virion-Bound Host ICAM-1 and Human Immunodeficiency Virus Type 1 Infectivity , 1998, Journal of Virology.

[39]  P. Gregersen,et al.  Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4 , 1998, Nature.

[40]  M. Lederman,et al.  In vivo analysis of Fas/FasL interactions in HIV-infected patients. , 1998, The Journal of clinical investigation.

[41]  C. Payá,et al.  The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection. , 1998, The Journal of clinical investigation.

[42]  C. Payá,et al.  CD4 Regulates Susceptibility to Fas ligand– and Tumor Necrosis Factor–mediated Apoptosis , 1998, The Journal of experimental medicine.

[43]  M. J. Tremblay,et al.  T Cells Expressing Activated LFA-1 Are More Susceptible to Infection with Human Immunodeficiency Virus Type 1 Particles Bearing Host-Encoded ICAM-1 , 1998, Journal of Virology.

[44]  A. Moses,et al.  The influence of human immunodeficiency virus-1 on hematopoiesis. , 1998, Blood.

[45]  C. Van Lint,et al.  Distinct Mechanisms Trigger Apoptosis in Human Immunodeficiency Virus Type 1-Infected and in Uninfected Bystander T Lymphocytes , 1998, Journal of Virology.

[46]  M. Prevost,et al.  Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods. , 1997, Journal of immunological methods.

[47]  D. Weissman,et al.  Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor , 1997, Nature.

[48]  E. Clercq,et al.  Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4 , 1997, The Journal of experimental medicine.

[49]  K. Ikuta,et al.  Exposure of resting peripheral blood T cells to HIV-1 particles generates CD25+ killer cells in a small subset, leading to induction of apoptosis in bystander cells. , 1997, International immunology.

[50]  S. Uccini,et al.  Death of bystander cells by a novel pathway involving early mitochondrial damage in human immunodeficiency virus-related lymphadenopathy. , 1997, Blood.

[51]  M. Tremblay,et al.  Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity , 1997, Journal of virology.

[52]  M. Tremblay,et al.  The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity , 1997, Journal of virology.

[53]  J. Sodroski,et al.  CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia , 1997, Nature.

[54]  A. Capron,et al.  Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule. , 1997, The Journal of clinical investigation.

[55]  K. Ikuta,et al.  Protease-defective, gp120-containing human immunodeficiency virus type 1 particles induce apoptosis more efficiently than does wild-type virus or recombinant gp120 protein in healthy donor-derived peripheral blood T cells , 1997, Journal of clinical microbiology.

[56]  J. Tschopp,et al.  Apoptosis of Fashigh CD4+ Synovial T Cells by Borrelia-reactive Fas-ligandhigh γδ T Cells in Lyme Arthritis , 1996, The Journal of experimental medicine.

[57]  H. Katinger,et al.  Acquisition of host cell‐surface‐derived molecules by HIV‐1 , 1996, AIDS.

[58]  S. Nagata,et al.  Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. , 1996, Blood.

[59]  J. Sodroski,et al.  Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1 , 1996, Journal of virology.

[60]  S. Zolla-Pazner,et al.  Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1 , 1995, The Journal of experimental medicine.

[61]  G. Luzi,et al.  Frequency of provirus-bearing CD4+ cells in HIV type 1 infection correlates with extent of in vitro apoptosis of CD8+ but not of CD4+ cells. , 1995, AIDS research and human retroviruses.

[62]  J. Margolick,et al.  Failure of T-cell homeostasis preceding AIDS in HIV-1 infection , 1995, Nature Medicine.

[63]  P. Krammer,et al.  Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120 , 1995, Nature.

[64]  L. Herzenberg,et al.  Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals , 1995, The Journal of experimental medicine.

[65]  A. Fauci,et al.  Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. , 1995, Journal of immunology.

[66]  M. Roederer,et al.  CD8 naive T cell counts decrease progressively in HIV-infected adults. , 1995, The Journal of clinical investigation.

[67]  V. Metelev,et al.  Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. , 1995, Science.

[68]  T. Curiel,et al.  Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes , 1995, Nature Medicine.

[69]  M. Martin,et al.  Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1 , 1994, Journal of virology.

[70]  P. Linsley,et al.  Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[71]  B. Autran,et al.  A Novel Mode of Human Immunodeficiency Virus Type 1 (HIV-1) Activation: Ligation of CD28 Alone Induces HIV-1 Replication in Naturally Infected Lymphocytes , 1993, Journal of Virology.

[72]  M. Kieny,et al.  Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. , 1993, AIDS research and human retroviruses.

[73]  P. Sharp,et al.  A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. , 1993, Virology.

[74]  D. Dimitrov,et al.  Quantitation of human immunodeficiency virus type 1 infection kinetics , 1993, Journal of virology.

[75]  S. J. Clark,et al.  High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. , 1993, Science.

[76]  L. Arthur,et al.  Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. , 1992, Science.

[77]  N. Haigwood,et al.  Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis , 1992, The Journal of experimental medicine.

[78]  F. Miedema,et al.  Programmed death of T cells in HIV-1 infection. , 1992, Science.

[79]  R. Desrosiers,et al.  Stable growth transformation of human T lymphocytes by herpesvirus saimiri. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[80]  M. Emerman,et al.  Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. , 1991, Virology.

[81]  J. Moore,et al.  Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization , 1991, Journal of virology.

[82]  M. Clerici,et al.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. , 1989, The Journal of clinical investigation.

[83]  R. Gallo,et al.  Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line. , 1981, Virology.

[84]  J. Giguère,et al.  New Insights into the Functionality of a Virion-Anchored Host Cell Membrane Protein: CD28 Versus HIV Type 1 , 2002 .

[85]  O. Vainio,et al.  MHC class II β-chain and αIIbβ3 integrin are expressed on T-cell progenitors in embryonic bone marrow , 2001 .

[86]  J. Moore,et al.  AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor , 1998, Nature Medicine.

[87]  V. Kuchroo,et al.  CD28/B7 costimulation: a review. , 1998, Critical reviews in immunology.

[88]  D. Vergani,et al.  Markers of immune cell activation and disease progression. Cell activation in HIV disease. , 1995, Advances in experimental medicine and biology.